Market News

Latest financial and economic news and analysis

PRNewsWire News Agency
6 days ago•PRNewsWire
Stocks Medium Importance Neutral
Robert Half honored by Forbes as one of America's Best Employers for Women 2026

Robert Half honored by Forbes as one of America's Best Employers for Women 2026

MENLO PARK, Calif., Aug. 5, 2026 /PRNewswire/ -- Global talent solutions and business consulting firm Robert Half (NYSE: RHI) has been recognized by Forbes as one of America's Best Employers for Women 2026.

Related Symbols 1
EIG EIG
Source: PRNewsWire
Visit Source
0 0 0
Read More
Comment
Seeking Alpha News Agency
6 days ago•Seeking Alpha
Stocks Medium Importance Neutral
Booking Holdings: At

Booking Holdings: At

Booking Holdings reported strong Q2 results, driving a ~5% post-earnings rally despite lagging the S&P 500 YTD. I maintain a 'Buy' rating on BKNG, emphasizing its growth at a reasonable price amid current market exuberance. BKNG continues to deliver healthy bookings and margin gains, even as the Iran war introduces some operational uncertainty.

Related Symbols 1
BKNG BKNG
Source: Seeking Alpha
Visit Source
0 0 0
Read More
Comment
Zacks Investment Research News Agency
6 days ago•Zacks Investment Research
Stocks Medium Importance Neutral
Can MRVL's Communications Recovery Drive Broad-Based Growth?

Can MRVL's Communications Recovery Drive Broad-Based Growth?

Marvell Technology's MRVL communications and other business segment has been recovering as customer inventories normalize. In the first quarter of fiscal 2027, communications and other revenues increased 29% year over year to $585 million.

Related Symbols 1
MRVL MRVL
Source: Zacks Investment Research
Visit Source
0 0 0
Read More
Comment
Zacks Investment Research News Agency
6 days ago•Zacks Investment Research
Stocks Medium Importance Neutral
AMGN Beats on Q2 Earnings, Lifts Outlook Despite Legacy Drug Pressure

AMGN Beats on Q2 Earnings, Lifts Outlook Despite Legacy Drug Pressure

Amgen beats Q2 earnings and revenue estimates and lifts its 2026 outlook. Key products witness strong growth despite biosimilar pressure on older drugs.

Related Symbols 1
AMGN AMGN
Source: Zacks Investment Research
Visit Source
Special Offer LiteFinance Start Trading
0 0 0
Read More
Comment
Proactive Investors News Agency
6 days ago•Proactive Investors
Stocks Medium Importance Neutral
SolarEdge forecasts weaker Q3 as US residential market remains challenging

SolarEdge forecasts weaker Q3 as US residential market remains challenging

SolarEdge Technologies (NASDAQ:SEDG) shares fell about 24% on Wednesday after the solar technology company issued a weaker-than-expected third quarter outlook, overshadowing better-than-expected second quarter results. The company guided for Q3 2026 revenue of $310 million to $340 million, with a midpoint of $325 million, below analyst expectations of roughly $368 million to $372 million.

Related Symbols 1
SEDG SEDG
Source: Proactive Investors
Visit Source
0 0 0
Read More
Comment
Seeking Alpha News Agency
6 days ago•Seeking Alpha
Stocks Medium Importance Neutral
HF Sinclair: In A Sweet Spot If Russian Supply Does Not Return

HF Sinclair: In A Sweet Spot If Russian Supply Does Not Return

HF Sinclair (DINO) is rated Buy, with 50% upside to a $133 price target, driven by sustained tightness in global refined products markets. DINO's diversified model, including midstream and marketing, buffers refining margin volatility; the upcoming lubricants spinoff provides additional upside potential. Consensus forecasts underestimate the duration of elevated crack spreads, assuming rapid normalization, while my base case expects prolonged high margins due to persistent geopolitical disruptions.

Related Symbols 1
DINO DINO
Source: Seeking Alpha
Visit Source
0 0 0
Read More
Comment
Market Watch News Agency
6 days ago•Market Watch
Stocks Medium Importance Neutral
How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?

How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?

The Danish company developed the most lucrative new drug the world had ever seen. Then America's Eli Lilly outmaneuvered it and took control of the diet-drug market.

Related Symbols 1
GLP GLP
Source: Market Watch
Visit Source
0 0 0
Read More
Comment